Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells

Mukesh Pandey, Sarvesh Kumar, Rajesh K. Thimmulappa, Virinder S. Parmar, Shyam Biswal, Arthur C. Watterson

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a central transcription factor that regulates the anti-oxidant defense system and is considered as a modifier for several inflammatory diseases. Thus, activation of Nrf2 provides pivotal therapeutic target for developing therapy against these diseases. Herein, a chemo-enzymatic methodology is designed and developed to make PEGylated curcumins as water soluble drug candidates with enhanced aqueous solubility and bioavailability. For this, curcumin was judiciously converted to diester (1) using ethyl α-bromoacetate and potassium carbonate. The diester 1 in subsequent step was copolymerized with poly(ethylene glycol) using Candida antarctica lipase [CAL-B, Novozym 435] under solventless condition. C. antarctica selectively does trans-esterification and only catalyses reaction of the primary hydroxyls of poly(ethylene glycol). It does not affect the secondary enolic hydroxyls of curcumin, thus leaving behind the active group unaltered. A luciferase based reporter gene assay was used for primary screening for identifying a novel Nrf2 activator. Most of the PEGylated curcumin analogs strongly activate Nrf2 several folds higher than the free curcumin but copolymer 3a was identified as the most potent Nrf2 activator. Copolymer 3a induces Nrf2-driven NQO1 expression in a concentration dependent manner. Furthermore, a plausible mechanism for quantitative structure-activity relationship is also discussed.

Original languageEnglish (US)
Pages (from-to)16-24
Number of pages9
JournalEuropean Journal of Pharmaceutical Sciences
Volume43
Issue number1-2
DOIs
StatePublished - May 18 2011
Externally publishedYes

Fingerprint

Curcumin
Epithelial Cells
Ethylene Glycol
Hydroxyl Radical
Quantitative Structure-Activity Relationship
Esterification
Luciferases
Reporter Genes
Oxidants
Solubility
Biological Availability
Transcription Factors
Water
Therapeutics
Pharmaceutical Preparations

Keywords

  • chemo-Enzymatic synthesis
  • Novozym 435
  • Nrf2
  • PEGylated curcumin

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. / Pandey, Mukesh; Kumar, Sarvesh; Thimmulappa, Rajesh K.; Parmar, Virinder S.; Biswal, Shyam; Watterson, Arthur C.

In: European Journal of Pharmaceutical Sciences, Vol. 43, No. 1-2, 18.05.2011, p. 16-24.

Research output: Contribution to journalArticle

Pandey, Mukesh ; Kumar, Sarvesh ; Thimmulappa, Rajesh K. ; Parmar, Virinder S. ; Biswal, Shyam ; Watterson, Arthur C. / Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells. In: European Journal of Pharmaceutical Sciences. 2011 ; Vol. 43, No. 1-2. pp. 16-24.
@article{73cb7b6699424861939d9899f48b9821,
title = "Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells",
abstract = "Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a central transcription factor that regulates the anti-oxidant defense system and is considered as a modifier for several inflammatory diseases. Thus, activation of Nrf2 provides pivotal therapeutic target for developing therapy against these diseases. Herein, a chemo-enzymatic methodology is designed and developed to make PEGylated curcumins as water soluble drug candidates with enhanced aqueous solubility and bioavailability. For this, curcumin was judiciously converted to diester (1) using ethyl α-bromoacetate and potassium carbonate. The diester 1 in subsequent step was copolymerized with poly(ethylene glycol) using Candida antarctica lipase [CAL-B, Novozym 435] under solventless condition. C. antarctica selectively does trans-esterification and only catalyses reaction of the primary hydroxyls of poly(ethylene glycol). It does not affect the secondary enolic hydroxyls of curcumin, thus leaving behind the active group unaltered. A luciferase based reporter gene assay was used for primary screening for identifying a novel Nrf2 activator. Most of the PEGylated curcumin analogs strongly activate Nrf2 several folds higher than the free curcumin but copolymer 3a was identified as the most potent Nrf2 activator. Copolymer 3a induces Nrf2-driven NQO1 expression in a concentration dependent manner. Furthermore, a plausible mechanism for quantitative structure-activity relationship is also discussed.",
keywords = "chemo-Enzymatic synthesis, Novozym 435, Nrf2, PEGylated curcumin",
author = "Mukesh Pandey and Sarvesh Kumar and Thimmulappa, {Rajesh K.} and Parmar, {Virinder S.} and Shyam Biswal and Watterson, {Arthur C.}",
year = "2011",
month = "5",
day = "18",
doi = "10.1016/j.ejps.2011.03.003",
language = "English (US)",
volume = "43",
pages = "16--24",
journal = "European Journal of Pharmaceutical Sciences",
issn = "0928-0987",
publisher = "Elsevier",
number = "1-2",

}

TY - JOUR

T1 - Design, synthesis and evaluation of novel PEGylated curcumin analogs as potent Nrf2 activators in human bronchial epithelial cells

AU - Pandey, Mukesh

AU - Kumar, Sarvesh

AU - Thimmulappa, Rajesh K.

AU - Parmar, Virinder S.

AU - Biswal, Shyam

AU - Watterson, Arthur C.

PY - 2011/5/18

Y1 - 2011/5/18

N2 - Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a central transcription factor that regulates the anti-oxidant defense system and is considered as a modifier for several inflammatory diseases. Thus, activation of Nrf2 provides pivotal therapeutic target for developing therapy against these diseases. Herein, a chemo-enzymatic methodology is designed and developed to make PEGylated curcumins as water soluble drug candidates with enhanced aqueous solubility and bioavailability. For this, curcumin was judiciously converted to diester (1) using ethyl α-bromoacetate and potassium carbonate. The diester 1 in subsequent step was copolymerized with poly(ethylene glycol) using Candida antarctica lipase [CAL-B, Novozym 435] under solventless condition. C. antarctica selectively does trans-esterification and only catalyses reaction of the primary hydroxyls of poly(ethylene glycol). It does not affect the secondary enolic hydroxyls of curcumin, thus leaving behind the active group unaltered. A luciferase based reporter gene assay was used for primary screening for identifying a novel Nrf2 activator. Most of the PEGylated curcumin analogs strongly activate Nrf2 several folds higher than the free curcumin but copolymer 3a was identified as the most potent Nrf2 activator. Copolymer 3a induces Nrf2-driven NQO1 expression in a concentration dependent manner. Furthermore, a plausible mechanism for quantitative structure-activity relationship is also discussed.

AB - Nuclear factor (erythroid-derived 2)-like 2 (Nrf2) is a central transcription factor that regulates the anti-oxidant defense system and is considered as a modifier for several inflammatory diseases. Thus, activation of Nrf2 provides pivotal therapeutic target for developing therapy against these diseases. Herein, a chemo-enzymatic methodology is designed and developed to make PEGylated curcumins as water soluble drug candidates with enhanced aqueous solubility and bioavailability. For this, curcumin was judiciously converted to diester (1) using ethyl α-bromoacetate and potassium carbonate. The diester 1 in subsequent step was copolymerized with poly(ethylene glycol) using Candida antarctica lipase [CAL-B, Novozym 435] under solventless condition. C. antarctica selectively does trans-esterification and only catalyses reaction of the primary hydroxyls of poly(ethylene glycol). It does not affect the secondary enolic hydroxyls of curcumin, thus leaving behind the active group unaltered. A luciferase based reporter gene assay was used for primary screening for identifying a novel Nrf2 activator. Most of the PEGylated curcumin analogs strongly activate Nrf2 several folds higher than the free curcumin but copolymer 3a was identified as the most potent Nrf2 activator. Copolymer 3a induces Nrf2-driven NQO1 expression in a concentration dependent manner. Furthermore, a plausible mechanism for quantitative structure-activity relationship is also discussed.

KW - chemo-Enzymatic synthesis

KW - Novozym 435

KW - Nrf2

KW - PEGylated curcumin

UR - http://www.scopus.com/inward/record.url?scp=79955701862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79955701862&partnerID=8YFLogxK

U2 - 10.1016/j.ejps.2011.03.003

DO - 10.1016/j.ejps.2011.03.003

M3 - Article

C2 - 21426935

AN - SCOPUS:79955701862

VL - 43

SP - 16

EP - 24

JO - European Journal of Pharmaceutical Sciences

JF - European Journal of Pharmaceutical Sciences

SN - 0928-0987

IS - 1-2

ER -